Zhi Li Selected Research

Hypoxia (Hypoxemia)

3/2022	Chromatin Remodeling Induced by ARID1A Loss in Lung Cancer Promotes Glycolysis and Confers JQ1 Vulnerability.
12/2021	Cytochrome P450 2J2 inhibits the proliferation and angiogenesis of retinal vascular endothelial cells by regulating the Notch signaling pathway in a hypoxia-induced retinopathy model.
1/2021	Preparation of Gold Nanoparticles and Its Effect on Autophagy and Oxidative Stress in Chronic Kidney Disease Cell Model.
1/2021	Berberine protects human and rat cardiomyocytes from hypoxia/reoxygenation-triggered apoptosis.
11/2020	TET is targeted for proteasomal degradation by the PHD-pVHL pathway to reduce DNA hydroxymethylation.
11/2020	Electron-Accepting Micelles Deplete Reduced Nicotinamide Adenine Dinucleotide Phosphate and Impair Two Antioxidant Cascades for Ferroptosis-Induced Tumor Eradication.
1/2020	MicroRNA-214-5p protects against myocardial ischemia reperfusion injury through targeting the FAS ligand.
1/2018	Long non-coding RNA UCA1 upregulation promotes the migration of hypoxia-resistant gastric cancer cells through the miR-7-5p/EGFR axis.
12/2017	Tet1 facilitates hypoxia tolerance by stabilizing the HIF-α proteins independent of its methylcytosine dioxygenase activity.
1/2017	Hypoxia Induces Multidrug Resistance via Enhancement of Epidermal Growth Factor-Like Domain 7 Expression in Non-Small Lung Cancer Cells.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zhi Li Research Topics

Disease

296	Neoplasms (Cancer) 12/2022 - 02/2003
63	Neoplasm Metastasis (Metastasis) 04/2022 - 02/2003
49	Infections 10/2022 - 01/2002
44	Breast Neoplasms (Breast Cancer) 07/2022 - 07/2007
38	Stomach Neoplasms (Stomach Cancer) 01/2022 - 06/2014
34	Inflammation (Inflammations) 05/2022 - 03/2006
27	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 10/2003
22	Carcinogenesis 01/2022 - 05/2003
18	Nasopharyngeal Carcinoma 01/2020 - 02/2003
17	Wounds and Injuries (Trauma) 11/2021 - 03/2006
16	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2022 - 12/2012
16	Hypoxia (Hypoxemia) 03/2022 - 01/2012
15	Reperfusion Injury 01/2022 - 05/2013
13	Myocardial Infarction 01/2022 - 03/2013
13	Glioma (Gliomas) 01/2021 - 01/2012
11	Obesity 10/2022 - 03/2006
11	Type 2 Diabetes Mellitus (MODY) 09/2022 - 08/2005
11	Adenocarcinoma of Lung 04/2022 - 01/2016
11	Carcinoma (Carcinomatosis) 03/2022 - 03/2006
11	Lung Neoplasms (Lung Cancer) 03/2022 - 01/2014
11	Pain (Aches) 01/2022 - 06/2008
11	Insulin Resistance 01/2021 - 03/2006
10	Fibrosis (Cirrhosis) 01/2023 - 09/2004
10	Body Weight (Weight, Body) 11/2021 - 09/2005
9	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 08/2011
9	Hemorrhage 01/2020 - 04/2009
9	Atrial Fibrillation 01/2020 - 10/2013
9	Myocardial Ischemia (Ischemic Heart Diseases) 01/2020 - 03/2014
8	Osteosarcoma (Osteogenic Sarcoma) 01/2022 - 05/2014
8	COVID-19 06/2021 - 01/2020
8	Infarction (Infarctions) 01/2021 - 06/2005
8	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021 - 05/2012
8	Sepsis (Septicemia) 06/2020 - 02/2011
8	Adenocarcinoma 01/2020 - 03/2012
7	Prostatic Neoplasms (Prostate Cancer) 02/2022 - 02/2016
7	Colonic Neoplasms (Colon Cancer) 01/2022 - 05/2011
7	Melanoma (Melanoma, Malignant) 01/2022 - 11/2015
7	Cardiovascular Diseases (Cardiovascular Disease) 09/2021 - 04/2012
7	Lymphatic Metastasis 01/2021 - 09/2008
6	Lymphoma (Lymphomas) 03/2022 - 12/2011
6	Necrosis 01/2022 - 07/2017
6	Polyploidy 01/2021 - 09/2014
6	Pneumonia (Pneumonitis) 01/2021 - 01/2011
6	Multiple Myeloma 07/2020 - 07/2012
6	Papillary Thyroid Cancer 01/2019 - 09/2008
6	Ischemia 07/2016 - 01/2013

Drug/Important Bio-Agent (IBA)

107	Proteins (Proteins, Gene)FDA Link 03/2022 - 02/2003
44	Pharmaceutical PreparationsIBA 05/2022 - 07/2012
44	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2003
31	Messenger RNA (mRNA)IBA 01/2022 - 02/2003
29	MicroRNAs (MicroRNA)IBA 01/2023 - 01/2013
26	Biological ProductsIBA 02/2022 - 01/2005
26	DNA (Deoxyribonucleic Acid)IBA 07/2021 - 09/2005
23	Long Noncoding RNAIBA 04/2022 - 01/2017
22	CytokinesIBA 01/2022 - 01/2004
18	RNA (Ribonucleic Acid)IBA 01/2022 - 06/2012
16	EnzymesIBA 01/2022 - 10/2006
14	Small Interfering RNA (siRNA)IBA 01/2022 - 03/2012
13	CateninsIBA 07/2022 - 01/2017
12	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2020 - 05/2004
10	Therapeutic UsesIBA 12/2022 - 10/2009
10	LipidsIBA 10/2022 - 05/2007
10	Transcription Factors (Transcription Factor)IBA 10/2022 - 04/2012
10	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 03/2013
10	Interleukin-6 (Interleukin 6)IBA 01/2022 - 03/2016
10	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 08/2006
10	Glucose (Dextrose)FDA LinkGeneric 11/2021 - 05/2007
10	SolutionsIBA 07/2021 - 03/2013
9	AntigensIBA 03/2022 - 06/2008
9	Retinaldehyde (Retinal)IBA 01/2022 - 01/2012
9	Macrophage Migration-Inhibitory FactorsIBA 01/2014 - 10/2003
9	Mucin-1 (CA 15-3 Antigen)IBA 02/2013 - 06/2010
8	Epidermal Growth Factor (EGF)IBA 01/2021 - 08/2009
8	Oxygen (Dioxygen)IBA 11/2020 - 01/2012
8	Interleukin-8 (Interleukin 8)IBA 01/2012 - 12/2003
7	AcidsIBA 11/2022 - 03/2019
7	Insulin (Novolin)FDA Link 01/2022 - 05/2007
7	Uric Acid (Urate)IBA 01/2022 - 05/2014
7	Cisplatin (Platino)FDA LinkGeneric 11/2021 - 06/2012
7	AntioxidantsIBA 05/2021 - 12/2015
7	GoldIBA 01/2021 - 02/2016
7	Cadherins (E-Cadherin)IBA 11/2020 - 02/2003
7	Paclitaxel (Taxol)FDA LinkGeneric 01/2020 - 02/2015
7	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2019 - 01/2012
6	N-methyladenosineIBA 10/2022 - 01/2021
6	Antiviral Agents (Antivirals)IBA 01/2022 - 01/2013
6	Circular RNAIBA 11/2021 - 01/2020
6	B7-H1 AntigenIBA 03/2021 - 01/2018
6	Metformin (Glucophage)FDA LinkGeneric 01/2021 - 09/2012
6	ErbB Receptors (EGF Receptor)IBA 01/2021 - 01/2019
6	VimentinIBA 11/2015 - 01/2011

Therapy/Procedure

96	Therapeutics 01/2023 - 10/2004
46	Drug Therapy (Chemotherapy) 01/2022 - 07/2007
16	Immunotherapy 12/2022 - 01/2015
13	Radiotherapy 04/2020 - 06/2010
7	Length of Stay 06/2022 - 12/2009
7	Adjuvant Chemotherapy 01/2022 - 12/2012
7	Precision Medicine 01/2022 - 07/2015
6	Aftercare (After-Treatment) 01/2022 - 07/2009
6	Gastrectomy 01/2021 - 01/2015